Essential thrombocytosis historical perspective: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
==Overview== | ==Overview== | ||
Essential thrombocytosis, also called as Epstein-Goedel syndrome was first described by pathologists Emil Epstein and Alfred Goedel in the year 1934 | Essential thrombocytosis, also called as Epstein-Goedel syndrome was first clearly described by pathologists Emil Epstein and Alfred Goedel in the year 1934<ref> | ||
==Historical perspective== | ==Historical perspective== | ||
Essential thrombocytosis, also called as Epstein-Goedel syndrome was first described by pathologists Emil Epstein and Alfred Goedel in the year 1934. | Essential thrombocytosis, also called as Epstein-Goedel syndrome was first described by pathologists Emil Epstein and Alfred Goedel in the year 1934.<ref>Kufe DW, Pollock RE, Weichselbaum RR, et al., editors.Hamilton (ON): BC Decker; 2003</ref> | ||
==References== | ==References== | ||
Revision as of 14:21, 30 October 2015
|
Essential thrombocytosis Microchapters |
|
Differentiating Essential thrombocytosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Essential thrombocytosis historical perspective On the Web |
|
American Roentgen Ray Society Images of Essential thrombocytosis historical perspective |
|
Risk calculators and risk factors for Essential thrombocytosis historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Essential thrombocytosis, also called as Epstein-Goedel syndrome was first clearly described by pathologists Emil Epstein and Alfred Goedel in the year 1934